|
|
Neural Mechanisms Driving Comorbid Parkinsons and Melanoma |
| 1F31CA268947-01 |
|
NCI |
2022 |
|
|
Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM |
| 1K08CA256045-01A1 |
|
NCI |
2022 |
|
|
Targeting Microenvironmental Signals in Myeloid Malignancies |
| 1R01CA266617-01 |
|
NCI |
2022 |
|
|
Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity |
| 1R01CA268125-01 |
|
NCI |
2022 |
|
|
Targeting Integrin Pathways by GLPG-0187 in Medulloblastoma |
| 1R21CA267365-01 |
|
NCI |
2022 |
|
|
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
| 1R37CA267905-01 |
|
NCI |
2022 |
|
|
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation |
| 1U01CA272268-01 |
|
NCI |
2022 |
|
|
sEcad as a novel target and therapy for IGF-1R expressing tumors |
| 3R01CA194409-08S1 |
|
NCI |
2022 |
|
|
Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases |
| 3R01CA219187-05S1 |
|
NCI |
2022 |
|
|
Design of de novo interleukin mimics for targeted immunotherapy |
| 3R01CA240339-04S1 |
|
NCI |
2022 |
